Company intelligence / Profile preview
Bio-Pharm Solutions
Suwon-si, Gyeonggi-do, South Koreab-psol.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bio‑Pharm Solutions has advanced its lead program for infantile spasms into Phase 2 clinical trials in the US. Its status epilepticus program is in Phase 1. The company has expanded its pipeline to include programs for Alzheimer’s and Parkinson’s diseases, with preclinical work ongoing. The company received IND approval from the US FDA for its first epilepsy drug within five years of founding.
- Therapeutic areas
- Neurology
- Modalities
- Small molecule drug
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Joint research with National Institutes of Health (NIH)cooperation with global consulting networksinterest from global pharmaceutical companies
Beyond the preview
Go deeper on Bio-Pharm Solutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio-Pharm Solutions.